Priothera – Reviving a Shelved Novartis Drug to Tackle Post-Transplant Relapse in AML

When Novartis shelved mocravimod despite promising data, a small team of former developers saw untapped potential. Now at the helm of Priothera, they’re advancing the...The post Priothera – Reviving a Shelved Novartis Drug to Tackle Post-Transplant Relapse in AML appeared first on PharmaSource.

Read Full Article →